CANNASWEEP

WEEK OF APRIL 5, 2024


OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business.


If you have any questions or would like more information about any of the items below, please contact us.


We also track cannabis-related legislation introduced in the U.S. Congress.  If you would like to learn more about our Congressional Bill Tracker, please reach out to Ben Dash


Federal Executive Branch — Office of the President, Departments and Agencies

Recent FDA Remarks

  • Two FDA officials working on cannabis policy spoke at an industry panel on April 4.  [PoliticoPro subscriber only]
  • FDA speakers included FDA Senior Science Advisor and Cannabis Products Committee Lead Patrick Cournoyer, FDA Senior Public Health Advisor Norman Birenbaum, Center for Veterinary Medicine Deputy Director Charlotte Conway, and Office of Dietary Supplement Programs Director Cara Welch.  Among their remarks:
  • “[CBD and Delta-8 regulation] are two problems that are the consequence of the 2018 Farm Bill”  and “Both of those problems need a solution”
  • Regulating hemp-derived cannabis products does not fit within any existing regulatory pathway
  • FDA’s three main concerns are (and continue to be) liver toxicity, reproductive health, and drug interactions.  If CBD was submitted to FDA as a food additive, it would not be approved
  • Contaminants and the many formats for CBD products are also a concern, from inhaled products to food additives to products for animals
  • Congress needs to make a new regulatory pathway, though there is uncertainty as to whether Congress could simply direct the agency to create the pathway or whether additional legislation is needed.  A fully regulated market, however, is likely still years away. 
  • The FDA panelists would not comment on rescheduling.  FDA stated that they completed their process and that there was nothing further to speak to. 

U.S. Congress

Cannabis Rescheduling/Descheduling

  • Kamala Harris is gravely wrong about rescheduling marijuana (Opinion – The Hill)

The States

Cannabis Abroad

  • Cannabis Is Officially Legal In Germany – What You Need To Know: (1) Cannabis users celebrate relaxation of laws on personal use in Germany (The Guardian); (2) Germany becomes the largest EU country to legalize cannabis for recreational use (La Monde – France); (3) Who benefits from the legalization of cannabis in Germany? (North Macedonia); (4) Germany becomes the biggest E.U. country to legalize marijuana possession (The Washington Post); and (5) Germans celebrate as recreational cannabis use becomes legal (CNN)
  • Austria stepping up police checks in border areas after Germany liberalizes cannabis rules
  • Medical cannabis could soon get the green light in France after an unprecedented trial
  • Marijuana in Thailand will be regulated, not banned: Public Health Minister

Business, Banking, Insurance

  • The Big Problem for Marijuana Companies? What to Do With All That Cash. Few banks will work with cannabis upstarts—but some lawmakers hope to change that this year (The Wall Street Journal)
  • OSHA Enforcement and Guidance on Protecting Workers within the Cannabis Industry – Webinar Series
  • Medical Marijuana: New Court Ruling on Impairment at Work

Other Noteworthy Updates

  • 9 Out Of 10 Americans Support Legalizing Marijuana, New Poll Finds (Forbes)
  • Large Review Finds CBD Products Don’t Relieve Chronic Pain After All
  • Study: Medical Marijuana Use Rises as Prescription Pain Reliever Dips
  • Patients keep asking if they should take cannabis for their cancer. The answer is still no (The Guardian)
  • How Do US Hemp-Derived Cannabinoid Sales and Craft Beer Sales Compare? The U.S. hemp-derived cannabinoid market is “conservatively” estimated to be $28.4 billion, according to Whitney Economics’ “2023 National Cannabinoid Report,” making the market size the same as the 2022 craft beer market.

***


If you are interested in exploring commercial opportunities in the cannabis space, we would be happy to assist you in any of your cannabis law questions, comments, or concerns. Please contact Tish Pahl (tpahl@ofwlaw.com), Kyla Kaplan (kkaplan@ofwlaw.com), Denise Calle (dcalle@ofwlaw.com), and Ben Dash (bdash@ofwlaw.com) for assistance.

More From ,

CANNASWEEP

CANNASWEEP

CANNASWEEP

CANNASWEEP

CANNASWEEP

CANNASWEEP

CANNASWEEP

Subscribe

Subscribe to receive OFW’s Food & Agriculture World Insights Newsletter.